| Data |
Ora |
Fonte |
Titolo |
|---|
| 20/11/2023 | 22:00 | EDGAR2 | Form 15-12G - Securities registration termination [Section.. |
| 20/11/2023 | 06:15 | EDGAR2 | Form EFFECT - Notice of Effectiveness |
| 09/11/2023 | 22:13 | EDGAR2 | Form 4 - Statement of changes in beneficial ownership of.. |
| 09/11/2023 | 22:05 | EDGAR2 | Form POS AM - Post-Effective amendments for registration.. |
| 09/11/2023 | 22:03 | EDGAR2 | Form S-8 POS - Securities to be offered to employees in.. |
| 09/11/2023 | 15:29 | EDGAR2 | Form 8-K - Current report |
| 08/11/2023 | 17:30 | GLOBE | Revolution Medicines and EQRx Stockholders Approve EQRx.. |
| 06/11/2023 | 22:10 | EDGAR2 | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
| 01/11/2023 | 13:02 | EDGAR2 | Form DEFA14A - Additional definitive proxy soliciting.. |
| 01/11/2023 | 12:59 | EDGAR2 | Form 425 - Prospectuses and communications, business.. |
| 01/11/2023 | 12:57 | EDGAR2 | Form 8-K - Current report |
| 16/8/2023 | 14:07 | EDGAR2 | Form 425 - Prospectuses and communications, business.. |
| 08/8/2023 | 23:29 | EDGAR2 | Form 425 - Prospectuses and communications, business.. |
| 08/8/2023 | 23:20 | EDGAR2 | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
| 03/8/2023 | 22:06 | EDGAR2 | Form 8-K - Current report |
| 01/8/2023 | 22:38 | EDGAR2 | Form 425 - Prospectuses and communications, business.. |
| 01/8/2023 | 22:32 | EDGAR2 | Form 425 - Prospectuses and communications, business.. |
| 01/8/2023 | 22:31 | EDGAR2 | Form 425 - Prospectuses and communications, business.. |
| 01/8/2023 | 22:29 | EDGAR2 | Form 425 - Prospectuses and communications, business.. |
| 01/8/2023 | 13:25 | EDGAR2 | Form 425 - Prospectuses and communications, business.. |
| 01/8/2023 | 13:19 | EDGAR2 | Form 8-K - Current report |
| 01/8/2023 | 13:00 | GLOBE | Revolution Medicines, Inc. to Acquire EQRx, Inc. in.. |
| 04/7/2023 | 00:29 | EDGAR2 | Form 4 - Statement of changes in beneficial ownership of.. |
| 08/5/2023 | 22:01 | GLOBE | EQRx Resets to Focus on Clinically Differentiated.. |
